By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:



Company News
Ignyta (RXDX) Announces Initiation Of Phase 1/1b Clinical Trial Of Taladegib In Combination With Paclitaxel By Cancer Research UK 2/4/2016 10:23:53 AM
Ignyta (RXDX) To Present At Leerink Partners 5th Annual Global Healthcare Conference 2/2/2016 11:28:33 AM
Ignyta (RXDX) Reports Granting Of Inducement Awards 1/18/2016 10:18:20 AM
Ignyta (RXDX) Unveils "5X5" Goal And Announces 2016 Strategic Priorities 1/11/2016 2:23:39 PM
Ignyta (RXDX) To Present At 34th Annual J.P. Morgan Healthcare Conference 1/7/2016 11:51:19 AM
Ignyta (RXDX) Reports Granting Of Inducement Awards 12/16/2015 11:27:07 AM
Ignyta (RXDX) Announces Accreditation Of Its Diagnostic Laboratory By College of American Pathologists 12/14/2015 1:06:03 PM
Ignyta (RXDX) Announces Initiation Of STARTRK "Next Generation" Phase 1/1b Pediatric Clinical Trial Of Entrectinib 12/9/2015 10:49:22 AM
Ignyta (RXDX) Receives Orphan Drug Designation In The European Union For Entrectinib For The Treatment Of Neuroblastoma 12/8/2015 12:18:39 PM
Ignyta (RXDX) Appoints William Mccarthy As Chief Business Officer 12/7/2015 10:59:18 AM